10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001651308-21-000172`
Period End Date	20210630
Filing Date	20210805
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	bgne-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 91 Income Statement 82 Cash Flow Statement 95 Stockholders Equity 38 Comprehensive Income 30

Balance Sheet 91 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38B	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.78B	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.35B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$307.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.20B	shares	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.19B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$310.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$283.00K	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$2.61B	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.19B	shares	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.20B	shares	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$3.27B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$60.40M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$73.79M	USD	Point-in-time
Inventories	`InventoryNet`	$117.59M	USD	Point-in-time
Inventories	`InventoryNet`	$89.29M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$160.01M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$225.46M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.80B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.96B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$7.75M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$9.93M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.60M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$395.17M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$357.69M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$95.98M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$90.58M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$12.01M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.00M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$65.96M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$79.75M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$132.24M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$113.09M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$725.08M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$640.07M	USD	Point-in-time
Total assets	`Assets`	$5.60B	USD	Point-in-time
Total assets	`Assets`	$5.52B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$231.96M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$168.83M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$398.86M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$346.14M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$63.60M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$13.86M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$20.38M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$13.89M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$16.55M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$145.82M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$127.81M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.19B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.81B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$434.80M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$335.01M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.24B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.08B	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$183.64M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$194.86M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.20B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.26B	CNY	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	-	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$75.27M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$29.42M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$34.17M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$12.27M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$10.79M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$303.13M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$375.04M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$55.33M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$57.43M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$675.03M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$656.32M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.92B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.73B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,204,567,023 and 1,190,821,941 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$120.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,204,567,023 and 1,190,821,941 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$118.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.41B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.56B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$12.10M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$6.94M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.97B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.55B	USD	Point-in-time
Total equity	`StockholdersEquity`	$3.61B	USD	Point-in-time
Total equity	`StockholdersEquity`	$3.87B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$5.52B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$5.60B	USD	Point-in-time

Income Statement 82 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$65.64M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$117.69M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$149.99M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$755.86M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$36.26M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$28.46M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$14.31M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$68.95M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$356.09M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$676.82M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$590.27M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$285.97M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$124.05M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$231.13M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$232.29M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$414.39M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$492.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$304.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$188.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$471.00K	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$624.83M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.16B	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$850.33M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$424.51M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-732.63M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-404.67M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-358.88M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-474.84M	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNet`	$-4.87M	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNet`	$-9.04M	USD	2 Qtrs
Interest (expense) income, net	`InterestIncomeExpenseNet`	$1.11M	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNet`	$7.80M	USD	2 Qtrs
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$23.66M	USD	2 Qtrs
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-867.00K	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$19.98M	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-4.99M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-701.18M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-480.57M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-418.71M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-337.79M	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-1.48M	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-230.00K	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$79.00K	USD	2 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-4.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$66.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-480.34M	USD	1 Quarter
Net loss	`ProfitLoss`	$-701.26M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-413.85M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.32M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.12M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-413.85M	USD	2 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-335.20M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-480.34M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-698.94M	USD	2 Qtrs
Loss per share attributable to BeiGene, Ltd. (in dollars per share)	`EarningsPerShareBasic`	$-0.69	USD	2 Qtrs
Loss per share attributable to BeiGene, Ltd. (in dollars per share)	`EarningsPerShareBasic`	$-0.33	USD	1 Quarter
Loss per share attributable to BeiGene, Ltd. (in dollars per share)	`EarningsPerShareBasic`	$-0.35	USD	2 Qtrs
Loss per share attributable to BeiGene, Ltd. (in dollars per share)	`EarningsPerShareBasic`	$-0.40	USD	1 Quarter
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.01B	shares	1 Quarter
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.01B	shares	2 Qtrs
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.19B	shares	2 Qtrs
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.19B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.01B	shares	2 Qtrs
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.01B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.19B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.19B	shares	2 Qtrs
Loss per American Depositary Share ("ADS") (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$-4.31	USD	1 Quarter
Loss per American Depositary Share ("ADS") (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$-5.23	USD	1 Quarter
Loss per American Depositary Share ("ADS") (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$-4.52	USD	2 Qtrs
Loss per American Depositary Share ("ADS") (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$-9.01	USD	2 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	77.71M	shares	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	77.54M	shares	2 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	91.66M	shares	2 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	91.85M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	77.71M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	91.85M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	91.66M	shares	2 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	77.54M	shares	2 Qtrs

Cash Flow Statement 95 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$66.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-480.34M	USD	1 Quarter
Net loss	`ProfitLoss`	$-701.26M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-413.85M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$21.16M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$15.62M	USD	2 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$110.62M	USD	2 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$83.72M	USD	2 Qtrs
Unrealized losses/(gains) on equity investments	`IncomeLossFromEquityMethodInvestments`	$11.26M	USD	2 Qtrs
Unrealized losses/(gains) on equity investments	`IncomeLossFromEquityMethodInvestments`	$-6.03M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$43.00M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$53.50M	USD	2 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-55.24M	USD	2 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-53.90M	USD	2 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-1.06M	USD	2 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-12.31M	USD	2 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$11.21M	USD	2 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$-7.06M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-9.09M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$13.34M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$28.29M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$4.68M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$51.96M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$77.20M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$34.85M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-42.56M	USD	2 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.69M	USD	2 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$41.47M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$138.88M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	-	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-108.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.19M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-295.17M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-604.89M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$80.92M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$54.14M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$2.44B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$1.36B	USD	2 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$2.00B	USD	2 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$997.24M	USD	2 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$43.00M	USD	2 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$8.50M	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$2.02M	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$7.50M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.54B	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$543.54M	USD	2 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	$2.16B	USD	2 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from research and development cost share liability	`ProceedsFromResearchAndDevelopmentFinancingLiability`	$616.83M	USD	2 Qtrs
Proceeds from research and development cost share liability	`ProceedsFromResearchAndDevelopmentFinancingLiability`	-	USD	2 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$49.52M	USD	2 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$10.82M	USD	2 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$26.20M	USD	2 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$112.59M	USD	2 Qtrs
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	-	USD	2 Qtrs
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	$15.96M	USD	2 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$35.60M	USD	2 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$28.20M	USD	2 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$9.85M	USD	1 Quarter
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$11.63M	USD	1 Quarter
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$25.75M	USD	1 Quarter
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$16.57M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$143.05M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.88B	USD	2 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-4.29M	USD	2 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.26M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$396.68M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$729.12M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.77M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.35B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.79B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.77M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.35B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.79B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.78B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.35B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$307.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$310.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$283.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$7.75M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$9.93M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.60M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$9.25M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$14.53M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$3.35M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$14.27M	USD	2 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$28.96M	USD	2 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$28.89M	USD	2 Qtrs
Acquired in-process research and development included in accrued expenses	`AcquiredInProcessResearchAndDevelopmentButNotYetPaid`	-	USD	2 Qtrs
Acquired in-process research and development included in accrued expenses	`AcquiredInProcessResearchAndDevelopmentButNotYetPaid`	$45.00M	USD	2 Qtrs

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.61B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.83B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.55B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.87B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.00B	USD	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.19B	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.20B	shares	Point-in-time
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$35.60M	USD	2 Qtrs
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$28.20M	USD	2 Qtrs
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$9.85M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$11.63M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$25.75M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$16.57M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$38.26M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$45.47M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$64.79M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$45.83M	USD	1 Quarter
Deconsolidation of entity	`NoncontrollingInterestDecreaseFromDeconsolidation`	$3.54M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.74M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$5.15M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-3.74M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$8.89M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.35M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$66.50M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-480.34M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-701.26M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-413.85M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-364.94M	USD	1 Quarter
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.61B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.83B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.55B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.87B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.00B	USD	Point-in-time
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	1.19B	shares	Point-in-time
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	1.20B	shares	Point-in-time

Comprehensive Income 30 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$66.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-480.34M	USD	1 Quarter
Net loss	`ProfitLoss`	$-701.26M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-413.85M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.62M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.73M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$9.63M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$5.86M	USD	2 Qtrs
Pension liability adjustments	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-361.00K	USD	2 Qtrs
Pension liability adjustments	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Pension liability adjustments	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	2 Qtrs
Pension liability adjustments	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$136.00K	USD	1 Quarter
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-4.47M	USD	1 Quarter
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.23M	USD	2 Qtrs
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-599.00K	USD	1 Quarter
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.07M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-702.65M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-408.69M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-471.45M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-339.06M	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.10M	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-2.41M	USD	2 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-700.24M	USD	2 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-408.69M	USD	2 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-471.45M	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-337.95M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.